How many PET tracers do we need?

Journal of Nuclear Medicine

Volumn 52, Issue SUPPL. 2, 2011, Pages

  Schwaiger, Markus ^a   Wester, Hans Jürgen ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Diagnostic single photon imaging; PET; Therapeutic radiopharmaceuticals

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; 3' FLUOROTHYMIDINE F 18; 3,4 DIHYDROXYPHENYLALANINE F 18; AMYLOID PROTEIN; CITRATE GA 68; COPPER 64; ETHYLTYROSINE F 18; FLUORINE 18; FLUORODEOXYGLUCOSE F 18; GALLIUM 68; INDIUM 111; IODINE 123; IODINE 131; RADIOISOTOPE; RUBIDIUM 82; SODIUM FLOURIDE F 18; TECHNETIUM 99M; TRACER; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR; ZIRCONIUM 89;

ALZHEIMER DISEASE; BONE SCINTISCANNING; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; ISOTOPE LABELING; MOLECULAR IMAGING; MYOCARDIAL PERFUSION IMAGING; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MEDICINE; ONCOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSTATE CANCER; RADIOACTIVITY; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THYROID CANCER;

FLUORINE RADIOISOTOPES; GALLIUM RADIOISOTOPES; HUMANS; MOLECULAR IMAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOACTIVE TRACERS; RADIOPHARMACEUTICALS;

EID: 83755206280     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.110.085738     Document Type: Review

References (20)

1. Sokoloff L. Mapping local functional activity by measurement of local cerebral glucose utilization in the central nervous system of animals and man. Harvey Lect. 1983;79:77-143.
2. Phelps ME, Mazziotta JC. Positron emission tomography: human brain function and biochemistry. Science. 1985;228:799-809. (Pubitemid 15021439)
3. International Atomic Energy Agency. Directory of cyclotrons used for radionuclide production in member states: 2006 update. Vienna, Austria: International Atomic Energy Agency; 2006. IAEA-DCRP/2006.
4. 13N-ammonia and validation with microspheres in a pig model. Circulation. 2009;119:2333-2342.
5. 18F-FDG PET in brain tumors. Nucl Med Biol. 2009;36:779-787.
6. Schlapschy M, Theobald I, Mack H, Schottelius M, Wester HJ, Skerra A. Fusion of a recombinant antibody fragment with a homo-amino-acid polymer: effects on biophysical properties and prolonged plasma half-life. Protein Eng Des Sel. 2007;20:273-284. (Pubitemid 47227182)
7. Picchio M, Briganti A, Fanti S, et al. The role of choline positron emission tomography/computed tomography in the management of patients with prostate-specific antigen progression after radical treatment of prostate cancer. Eur Urol. 2011;59:51-60.
8. 11C-choline PET/CT with histopathologic step-section analysis. J Nucl Med. 2005;46:1642-1649.
9. 99mTc-MAA microspheres. Appl Radiat Isot. 2011;69:171-175.
10. Kotzerke J, Andreeff M, Wunderlich G. PET aerosol lung scintigraphy using Galligas. Eur J Nucl Med Mol Imaging. 2010;37:175-177.
11. 68Ga-citrate PET/CT for evaluating patients with infections of the bone: preliminary results. J Nucl Med. 2010;51:1932-1936.
12. 68Ga-PET: a powerful generator-based alternative to cyclotron-based PET radiopharmaceuticals. Contrast Media Mol Imaging. 2008;3:67-77.
13. Bading JR, Shields AF. Imaging of cell proliferation: status and prospects. J Nucl Med. 2008;49(suppl 2):64S-80S. (Pubitemid 351948037)
14. Graf N, Herrmann K, den Hollander J, et al. Imaging proliferation to monitor early response of lymphoma to cytotoxic treatment. Mol Imaging Biol. 2008; 10:349-355.
15. 18F-FLT-uptake in patients with aggressive Non-Hodgkin lymphoma receiving R-CHOP treatment. J Nucl Med. 2011;52:690-696.
16. Weber WA. Assessing tumor response to therapy. J Nucl Med. 2009;50(suppl 1):1S-10S.
17. Wahl RL, Jacene H, Kasamon Y, Lodge MA. From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors. J Nucl Med. 2009;50(suppl 1):122S-150S.
18. Mas-Moruno C, Rechenmacher F, Kessler H. Cilengitide: the first anti-angiogenic small molecule drug candidate design, synthesis and clinical evaluation. Anticancer Agents Med Chem. 2010;10:753-768.
19. Libby P, DiCarli M, Weissleder R. The vascular biology of atherosclerosis and imaging targets. J Nucl Med. 2010;51(suppl 1):33S-37S.
20. Rudd JH, Hyafil F, Fayad ZA. Inflammation imaging in atherosclerosis. Arterioscler Thromb Vasc Biol. 2009;29:1009-1016.